Search clinical trials for: HER2-positive melanoma

Total 4149 results

Dana-Farber Cancer Institute
Massachusetts General Hospital; GlaxoSmithKline; Brigham and Women's Hospital; North...

Completed

Trastuzumab in Combination With Vinorelbine or Taxane-Based Chemotherapy in Patients With Metastatic Breast Cancer

Breast Cancer | Stage IV Breast Cancer

United States
Royal Marsden NHS Foundation Trust

Unknown

The Identification of Novel Prognostic Markers in Melanoma

Malignant Melanoma

United Kingdom
University of Virginia

Completed

A Pilot Study of Intraoperative Gamma Camera Imaging During Sentinel Node Biopsy for Melanoma (MEL50)

Melanoma

United States
University of Sao Paulo General Hospital

Completed

Myofunctional Therapy in Facial Palsy

Facial Paralysis

Brazil
Radboud University Medical Center
Dutch Cancer Society

Completed

Peptide-pulsed vs. RNA-transfected Dendritic Cell Vaccines in Melanoma Patients

Melanoma Stage III or IV

Netherlands
Memorial Sloan Kettering Cancer Center

Completed

Intraoperative Mapping of Regional Lymphatics Draining the Primary Site of Melanoma Using Isosulfan Blue

Melanoma

United States
National Taiwan University Hospital
National Science Council, Taiwan

Completed

Randomized Trial of 24 or 48 Weeks of Peginterferon Alfa-2a Plus Ribavirin for HCV Genotype 1-infected Patients

Hepatitis C, Chronic

Taiwan
NeoPlas Innovation

Withdrawn

Evaluation of Interferon-Lovastatin Therapy for Malignant Melanoma

Melanoma | Malignant Melanoma

United States
Nova Scotia Health Authority

Unknown

Genetic Identification (ID) of Segmental Dysplastic Nevi

Segmental Dysplastic Nevi

Canada
Antisoma Research

Completed

Study of AS1409 in Patients With Either Metastatic Renal Cell Carcinoma or Metastatic Malignant Melanoma

Metastatic Renal Cell Carcinoma | Metastatic Malignant Melanoma

United Kingdom, New Zealand
Glostrup University Hospital, Copenhagen

Unknown

Intravesical Instillation of Botulinum Toxin Type A to Patients With Urge Urinary Incontinence

Urge Urinary Incontinence

Denmark
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Oxcarbazepine Oral Suspension 300 mg/5mL Under Fed Condition

Healthy

India
sigma-tau i.f.r. S.p.A.

Completed

Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant Melanoma

Malignant Melanoma

France, Germany, Hungary, Italy, Poland, Portugal, Spain, Switzerland
Leiden University Medical Center
Novartis Pharmaceuticals

Unknown

Treatment Of Radiation Retinopathy Trial (TORR)

Uveal Melanoma
Cadila Pharnmaceuticals

Terminated

Safety Study of CADI-05 in Patients With Advanced Stage Melanoma

Stage III or Stage IV Melanoma

United States
University of Virginia

Completed

Evaluation of the Effects of Local Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Adjuvant Administration on Dendritic Cells in Skin of Melanoma Patients and in Sentinel Lymph Nodes: MEL38 (MEL38)

Melanoma

United States
AstraZeneca
KuDOS Pharmaceuticals Limited

Completed

A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of PARP in Combination With Dacarbazine

Melanoma Neoplasms

United States, United Kingdom
TransMolecular

Terminated

A Safety and Efficacy Study of Intravenous 131I-TM601 in Adult Patients With Malignant Melanoma

Melanoma | Metastatic Melanoma | Malignant Melanoma

United States
University of Turku

Completed

Bevacizumab, Dacarbazine and Interferon-Alfa to Treat Metastatic Melanoma

Metastatic Melanoma

Finland
TransMolecular

Completed

131-I-TM-601 Study in Adults With Solid Tumors

Glioma | Melanoma | Breast Cancer | Colorectal Cancer | Pancreatic Cancer | Non-Small Cell Lung Cancer | Prostate Adenocarcinoma | Primary Solid Tumors

United States
Pfizer

Completed

PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909)

Melanoma | Carcinoma, Renal Cell | Breast Neoplasms | Carcinoma, Non-Small-Cell Lung | Lymphoma, T-Cell

United States, Germany
Genentech, Inc.

Terminated

A Study of Intravenous INO-1001 Plus Oral Temozolomide to Evaluate Tolerability, Safety, and Pharmacokinetics in Patients With Melanoma

Melanoma
ZymoGenetics

Completed

Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer

Melanoma | Kidney Neoplasms | Metastases

United States
Sunnaas Rehabilitation Hospital
The Royal Norwegian Ministry of Health

Completed

Effects of Botulinum Toxin Type A in Adults With Cerebral Palsy

Cerebral Palsy

Norway
Radboud University Medical Center
Dutch Cancer Society

Completed

Augmentation of Dendritic Cell-Based Vaccines in Melanoma Patients by Depletion of Regulatory T Cells in Stage IV Melanoma Patients

Melanoma
Radboud University Medical Center
Dutch Cancer Society

Completed

Dendritic Cell Vaccination in Melanoma Patients Scheduled for Regional Lymph Node Dissection

Melanoma Stage III or IV

Netherlands
University Hospital, Bonn
Hoffmann-La Roche

Terminated

Efficacy and Safety of PegIFN +/- FTC / TDF to Treat Chronic Hepatitis B in HIV-Coinfected Patients

HIV Infections | Chronic Hepatitis B

Germany
Pfizer

Completed

CPG 7909 Injection in Melanoma

Carcinoma, Melanoma
European Organisation for Research and Treatment...

Unknown

Vaccine Therapy in Treating Patients With Primary Stage II Melanoma

Melanoma (Skin)

Italy, France, Spain, Switzerland, United Kingdom, Belgium, Australia, Norway, Poland, Finland, Netherlands, Germany, Israel, Denmark, Serbia, Estonia, Portugal, Russian Federation
Baylor College of Medicine
National Cancer Institute (NCI)

Unknown

Low Fat Diet to Prevent Disease Progression in Patients With Skin Cancer

Non-Melanomatous Skin Cancer

United States
Dana-Farber Cancer Institute
National Cancer Institute (NCI)

Unknown

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Melanoma (Skin)

United States
Northern California Melanoma Center
Pfizer; Schering-Plough

Terminated

Temodar and Sutent as Therapy for Melanoma

Metastatic Malignant Melanoma

United States
Siemens Molecular Imaging

Completed

Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5 (K5)

Melanoma | Sarcoma | Breast Cancer | Lung Cancer | High Grade Gliomas

United States
US Department of Veterans Affairs
Ortho Dermatologics

Completed

Determine the Efficacy of Topical Tretinoin Cream for the Prevention of Nonmelanoma Skin Cancer

Carcinoma, Squamous Cell | Carcinoma, Basal Cell | Skin Neoplasms

United States
Tehran Hepatitis Center
Kermanshah University of Medical Sciences

Completed

Effectiveness and Side Effects of Pegylated Interferon Alpha-2a (Pegaferon®) Plus Ribavirin in the Patients With Chronic Hepatitis C

Hepatitis C

Iran, Islamic Republic of
Pfizer

Completed

Safety and Efficacy of an Immune Response Modifier to Treat Inoperable Advanced Melanoma Skin Lesions

Melanoma

United States
Pfizer

Completed

Use of 852A in Metastatic Cutaneous Melanoma.

Melanoma | Unresectable Metatstatic Cutaneous Melanoma

Switzerland, Germany, France
University of Wuerzburg
medac GmbH; Hiege-Stiftung gegen Hautkrebs; DCS Innovative Diagnostik Systeme

Unknown

Comparative Study of Individualized Sensitivity-Directed Chemotherapy Versus DTIC (ChemoSensMM)

Melanoma

Germany
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Modified Bone Marrow Stem Cell Transplantation for Chronic Myelogenous Leukemia

Chronic Myeloid Leukemia | Graft vs Host Disease

United States
PDL BioPharma, Inc.

Completed

Volociximab in Combination With DTIC in Patients With Metastatic Melanoma Not Previously Treated With Chemotherapy

Melanoma | Metastases

United States
Vical

Completed

Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma

Recurrent Melanoma | Stage IV Melanoma | Stage III Melanoma

United States
Nantes University Hospital

Completed

Treatment of Metastatic Melanoma With Autologous Melan-A/MART-1 Specific CTL Clones

Immunotherapy

France
Rigshospitalet, Denmark

Completed

Sentinel Node With Ultrasound Contrast in Melanoma

Malignant Melanoma

Denmark
Biopure Corporation

Terminated

Safety/Feasibility Study of HBOC-201 in Amputation at/Below Knee From Critical Lower Limb Ischemia

Peripheral Vascular Disease

United Kingdom, South Africa
Barnes Retina Institute

Unknown

Tilting of Radioactive Plaques After Initial Accurate Placement for Treatment of Uveal Melanoma

Uveal Melanoma

United States
Renovo

Unknown

A Trial to Investigate Scar Improvement Efficacy of RN1001 (Avotermin) After Head and Neck Naevi Excision

Cicatrix | Nevus

United Kingdom
Introgen Therapeutics
M.D. Anderson Cancer Center

Unknown

Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma

Neoplasm Metastasis | Malignant Melanoma

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of gp100 Human Melanoma Peptide Vaccine With Incomplete Freund's Adjuvant

Melanoma

United States
National Cancer Institute (NCI)

Completed

A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity Melanoma

Melanoma

United States
National Cancer Institute (NCI)

Completed

Immunization of HLA-A201 Patients With Metastatic Melanoma Using a Combination of Immunodominant Peptides From Three Melanoma Antigens, MART-1, GP100 and Tyrosinase

Melanoma | Neoplasm Metastasis

United States

Search clinical trials for: HER2-positive melanoma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations